Amarin Corp Plc (AMRN)

[KCSVEN]

I'm with you but WS is not a believer yet.

Superior product does not always equal superior sales.

Sure there are examples of companies in biotech at high multiples. PCYC has sales already and has a pipeline.

ALXN has a P/E of 66 and forward P/E of 35 but have sales already.

AMRN has no pipeline and has no BP partner and has 1 drug that many in WS look at as "fish oil". All these things WS does not like so they will need to prove a little more. If they do and sales ramp...

1 Billion a year in sales likely sees $30 share price. Reduce It positive likely sees $100 plus stock price.

WS likes to look 6 months ahead and very hard today to judge 1Q and 2Q 2014 sales-Will there be a partner, a cash raise for GIA Anchor, an increased sales force, a small initial launch...lots of questions that add more uncertainty to institutional investors.

You want many institutions to add AMRN to their positions, management has to clear up many questions they have, if they do we can see multiples like ALXN and other fast growing biotechs.